NCT05310045

Brief Summary

Today, 40% of cancers are linked to modifiable risk factors and could thus be preventable. Primary prevention, which allows individuals to be informed and aware of health recommendations and possible actions before the onset of a cancer, is thus a major public health issue. Around 11 million of French citizens are informal caregivers, i.e. people who regularly and frequently provide a non-professional help to do all or part of daily life activities for a dependent person with a disability, disease, or due to age. In cancer, there are around 5 million of informal caregivers in France. Studies have shown that informal caregivers of cancer patients are not only at risk for stress, anxiety, poor health, diminished quality of life, but also that they adopt so-called "risk behaviours" (e.g., increased smoking or alcohol consumption, unbalanced eating habits rich in fat, sugar and ultra-processed foods, sedentary lifestyle, etc.). These behaviours may develop or worsen co-morbidities and/or promote cancer development, outside hereditary context. Moreover, for certain types of cancer, related and unrelated family caregivers have a higher risk of developing cancer because they share the same lifestyle including the same risk factors. However, compared to general population, informal caregivers of cancer patients, have an increased risk perception and motivation to change a so-called unhealthy lifestyle. In this context, our goal is to test the feasibility and acceptability of a personalised primary prevention intervention designed to informal caregivers of cancer patients at increased risk of cancer. The intervention will be first designed to first-degree relatives and partners/spouses of a patient treated at Léon Bérard Center. Developed in the Léon Bérard comprehensive cancer centre in close relation with outpatient care and based on an informal caregiver's tracking questionnaire, the intervention will be composed of two consultations with a physician trained in primary prevention and information and referral to health prevention structures. As primary objectives, acceptability will be assessed based on informal caregivers' satisfaction and feasibility based on their participation rates. As secondary objectives, informal caregivers' knowledge and risk perception will be assessed based on questionnaires and intention to change or change behaviour will be noted and analysed through individual semi-structured interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 4, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

April 4, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2024

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

2.3 years

First QC Date

March 16, 2022

Last Update Submit

March 31, 2025

Conditions

Keywords

primary preventioninformal caregiverscancer riskpersonalised intervention

Outcome Measures

Primary Outcomes (2)

  • Acceptability of the intervention

    Acceptability will be assessed based on informal caregivers' satisfaction.

    At the end of the personalised primary prevention intervention (4 to 6 months after inclusion)

  • Feasibility of the intervention

    Feasibility will be assessed based on informal caregivers' participation rates.

    At the end of the personalised primary prevention intervention (4 to 6 months after inclusion)

Secondary Outcomes (6)

  • Adherence of informal caregivers to the different stages of the study: filling in the questionnaire

    At the pre-inclusion

  • Adherence of informal caregivers to the different stages of the study: attendance to consultations

    At the end of the 1st (2 to 6 weeks after inclusion) and the 2nd consultation (4 to 6 months after inclusion)

  • Experience, of informal caregivers who have benefited from all the personalised primary prevention intervention

    After the 2nd consultation (4 to 6 months after inclusion)

  • Short-term impact of the personalised primary prevention intervention: knowledge

    Before the 1st (2 to 6 weeks after inclusion) and the 2nd consultation (4 to 6 months after inclusion)

  • Short-term impact of the personalised primary prevention intervention: cancer risk perception

    Before the 1st (2 to 6 weeks after inclusion) and the 2nd consultation (4 to 6 months after inclusion)

  • +1 more secondary outcomes

Interventions

Personalised primary prevention intervention 1. Consultation 1 * Assess caregiver's situation regarding their cancer risk factors * Explain the causal links between risk factors and cancer * Inform about national recommendations to prevent and limit cancer risk * Clarify informal caregiver situation with respect to national screening programs * Define a personalised primary prevention program 2. Implementation: personalised primary prevention program * Carried out by the informal caregiver * Supervised by the coordinating nurse 3. Consultation 2 * Assess prevention actions realised by informal caregiver in relation to actions defined in the personalised primary prevention program * Identify barriers and facilitators to their implementation whether actions or no actions have been done. * Adapt the personalised primary prevention program to informal caregiver needs.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

First-degree relative and partner/spouse of a patient treated at the Centre Léon Bérard, at increased risk of cancer

You may qualify if:

  • First-degree relative and partner/spouse of a patient treated at the Centre Léon Bérard;
  • At increased risk of cancer
  • Aged between 18 and 75 years;
  • No diagnosis of genetic predisposition to cancer and no personal or informal history suggesting genetic predisposition;
  • Able to complete a questionnaire in French, alone or with the help of a relative (persons with visual, mute, motor, hearing or intellectual disabilities will be included as long as they are able to complete a questionnaire alone or with the help of a relative);
  • Being informed and not opposed to the study ;
  • Having completed the entire tracking questionnaire and wishing to be contacted.

You may not qualify if:

  • Related or unrelated relative not considered as an informal caregiver for the patient;
  • Minor informal caregiver;
  • Informal caregiver with a history of cancer;
  • Patient under care at the Institute of Hematology and Pediatric Oncology;
  • Individuals of legal age protected by law.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Leon Berard

Lyon, 69373, France

Location

Study Officials

  • Béatrice FERVERS

    Centre Léon Bérard (CLB)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2022

First Posted

April 4, 2022

Study Start

April 4, 2022

Primary Completion

July 15, 2024

Study Completion

July 15, 2024

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

We are not planning to share IPD

Locations